Circassia focused on developing immunotherapies for the treatment of allergies... Read more
Circassia focused on developing immunotherapies for the treatment of allergies... Read more
News
Aug 11, 2022
FE Investegate
Circassia Pharmaceuticals: Circassia Group Plc : Proposed Change of Name and Notice of GM
Jul 21, 2022
FE Investegate
Circassia Pharmaceuticals: Circassia Group Plc : Change of Auditor
Jul 14, 2022
FE Investegate
Circassia Pharmaceuticals: Circassia Group Plc : Trading Update
Jul 14, 2022
Business and Innovation Magazine
Circassia Pharmaceuticals: Oxford's Circassia releases financial figures for the first half of the year
Jun 29, 2022
MarketScreener
Circassia Pharmaceuticals: Circassia to Receive $10.5 Million After US Approval of Beyond Air's LungFit Product; Shares Rise
Jun 29, 2022
Business and Innovation Magazine
Circassia Pharmaceuticals: Oxford-based Circassia welcomes FDA approval for BeyondAir's LungFit device
May 27, 2022
FE Investegate
Circassia Pharmaceuticals: Circassia Group Plc : Extension of Block Admission
May 25, 2022
FE Investegate
Circassia Pharmaceuticals: Circassia Group Plc : Second Price Monitoring Extn
May 20, 2022
FE Investegate
Circassia Pharmaceuticals: Circassia Group Plc : Grant of Options
May 12, 2022
FE Investegate
Circassia Pharmaceuticals: Circassia Group Plc : AGM Statement
Circassia Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10